American Association for Cancer Research

The Lee W. Wattenberg Symposium - Cancer Chemoprevention: Past Achievements, Future Strategies

The Lee W. Wattenberg Symposium 2011

American Association for Cancer Research Masonic Cancer Center, University of Minnesota National Cancer Institute Comprehensive Cancer Center

Thursday, May 26

Welcome

10:30 a.m.-10:35 a.m.

Douglas Yee, Director, Masonic Cancer Center, University of Minnesota, Minneapolis, MN

Session 1

Chairperson: Margaret Foti, Chief Executive Officer, American Association for Cancer Research, Philadelphia, PA
10:35 a.m.-12:20 p.m.

Welcome and Remarks
Margaret Foti

Cancer prevention and its vital role in the conquest of cancer
Margaret Foti

Presentation of the AACR Award for Lifetime Achievement in Cancer Prevention Research

Late-stage inhibition and other strategies for prevention of neoplasia
Lee W. Wattenberg, Masonic Cancer Center, University of Minnesota, Minneapolis, MN

Extending the pioneering work of Lee Wattenberg on chemoprevention of lung carcinogenesis
Stephen S. Hecht, Masonic Cancer Center, University of Minnesota, Minneapolis, MN

Personalized approach in lung cancer: Reverse migration strategy
Waun Ki Hong, University of Texas MD Anderson Cancer Center, Houston, TX

Lunch

12:20 p.m.-1:05 p.m.

Session 2

Chairperson: Eva Szabo, National Cancer Institute, Bethesda, MD
1:05 p.m.-2:55 p.m.

Person-to-person differences in drug metabolism: Importance for cancer chemoprevention
Allan H. Conney, Rutgers, The State University of New Jersey, Piscataway, NJ

PPAR gamma activation as a strategy in aerodigestive cancer prevention: A surgeon's perspective
Frank G. Ondrey, Masonic Cancer Center, University of Minnesota, Minneapolis, MN

A pathway approach to lung cancer chemoprevention in high-risk smokers
Stephen Lam, British Columbia Cancer Agency, Vancouver, BC, Canada

Rethinking the runway for successful development of chemoprevention for the clinic: Hard lessons learned
Frank L. Meyskens Jr., University of California Irvine Chao Family Comprehensive Cancer Center, Orange, CA

From mouse to man: The budesonide story and what it has taught us
Eva Szabo

Closing Remarks

2:55 p.m.-3:00 p.m.